| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Stromal Tumors | 79 | 2022 | 643 | 11.000 |
Why?
|
| Proto-Oncogene Proteins c-kit | 85 | 2022 | 776 | 8.930 |
Why?
|
| Gastrointestinal Neoplasms | 39 | 2022 | 990 | 4.820 |
Why?
|
| Piperazines | 53 | 2019 | 2488 | 2.790 |
Why?
|
| Pyrimidines | 53 | 2021 | 2942 | 2.670 |
Why?
|
| Translocation, Genetic | 48 | 2018 | 1420 | 2.540 |
Why?
|
| Chromosome Aberrations | 48 | 2023 | 1813 | 2.380 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 24 | 2020 | 379 | 2.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 74 | 2021 | 2649 | 2.040 |
Why?
|
| Leiomyosarcoma | 10 | 2023 | 477 | 2.020 |
Why?
|
| Benzamides | 48 | 2016 | 1379 | 1.790 |
Why?
|
| Sarcoma | 23 | 2020 | 1897 | 1.790 |
Why?
|
| Oncogene Proteins, Fusion | 25 | 2020 | 1581 | 1.700 |
Why?
|
| Drug Resistance, Neoplasm | 34 | 2021 | 5172 | 1.660 |
Why?
|
| Protein Kinase Inhibitors | 33 | 2022 | 5535 | 1.540 |
Why?
|
| Oncogene Proteins | 11 | 2016 | 749 | 1.530 |
Why?
|
| Mesothelioma | 12 | 2023 | 818 | 1.520 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 15 | 2018 | 1660 | 1.380 |
Why?
|
| Sarcoma, Endometrial Stromal | 6 | 2018 | 91 | 1.320 |
Why?
|
| HSP90 Heat-Shock Proteins | 7 | 2019 | 434 | 1.260 |
Why?
|
| Mutation | 62 | 2022 | 29786 | 1.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 33 | 2021 | 8428 | 1.210 |
Why?
|
| Antineoplastic Agents | 53 | 2022 | 13695 | 1.200 |
Why?
|
| Karyotyping | 58 | 2010 | 1243 | 1.200 |
Why?
|
| Soft Tissue Neoplasms | 22 | 2016 | 1363 | 1.180 |
Why?
|
| DNA-Binding Proteins | 27 | 2023 | 9648 | 1.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 5 | 2016 | 380 | 1.100 |
Why?
|
| Gene Rearrangement | 22 | 2020 | 1179 | 1.030 |
Why?
|
| Uterine Neoplasms | 10 | 2021 | 1513 | 0.990 |
Why?
|
| Cell Proliferation | 32 | 2022 | 10481 | 0.970 |
Why?
|
| Proto-Oncogene Proteins | 12 | 2018 | 4554 | 0.960 |
Why?
|
| Chromosomes, Human, Pair 8 | 15 | 2013 | 460 | 0.940 |
Why?
|
| Dystrophin | 2 | 2015 | 285 | 0.910 |
Why?
|
| Bone Cysts, Aneurysmal | 4 | 2005 | 73 | 0.900 |
Why?
|
| Trisomy | 12 | 2010 | 266 | 0.880 |
Why?
|
| Genes, Tumor Suppressor | 10 | 2023 | 1097 | 0.870 |
Why?
|
| Chromosomes, Human, Pair 17 | 11 | 2012 | 437 | 0.870 |
Why?
|
| Cyclin D1 | 5 | 2019 | 463 | 0.860 |
Why?
|
| Bone Neoplasms | 14 | 2018 | 2529 | 0.850 |
Why?
|
| Cell Line, Tumor | 54 | 2022 | 16689 | 0.850 |
Why?
|
| Muscular Dystrophies | 2 | 2015 | 393 | 0.840 |
Why?
|
| Genes, p53 | 6 | 2021 | 755 | 0.840 |
Why?
|
| Transcription Factors | 34 | 2019 | 12208 | 0.770 |
Why?
|
| Chromosomes, Human, Pair 22 | 11 | 2019 | 351 | 0.770 |
Why?
|
| Signal Transduction | 51 | 2020 | 23403 | 0.770 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 97 | 0.750 |
Why?
|
| Liposarcoma | 6 | 2015 | 333 | 0.720 |
Why?
|
| Chromosomes, Human, Pair 12 | 10 | 2004 | 462 | 0.700 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2019 | 2503 | 0.700 |
Why?
|
| Phenothiazines | 1 | 2019 | 63 | 0.700 |
Why?
|
| Stromal Cells | 15 | 2004 | 1355 | 0.680 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2023 | 2948 | 0.670 |
Why?
|
| Dermatofibrosarcoma | 6 | 2015 | 63 | 0.670 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 6 | 2017 | 705 | 0.670 |
Why?
|
| Chromosome Deletion | 11 | 2019 | 1401 | 0.650 |
Why?
|
| Osteosarcoma | 4 | 2014 | 881 | 0.650 |
Why?
|
| Endometrial Neoplasms | 7 | 2018 | 1353 | 0.630 |
Why?
|
| Protein-Tyrosine Kinases | 12 | 2019 | 2455 | 0.630 |
Why?
|
| Chaperonins | 2 | 2019 | 62 | 0.630 |
Why?
|
| Leiomyoma | 6 | 2012 | 730 | 0.620 |
Why?
|
| 14-3-3 Proteins | 4 | 2013 | 214 | 0.610 |
Why?
|
| Pleural Neoplasms | 5 | 2018 | 607 | 0.610 |
Why?
|
| Genes, erbB-2 | 4 | 2003 | 162 | 0.600 |
Why?
|
| Immunohistochemistry | 39 | 2021 | 11366 | 0.590 |
Why?
|
| Humans | 330 | 2023 | 744343 | 0.590 |
Why?
|
| Tandem Repeat Sequences | 1 | 2018 | 185 | 0.580 |
Why?
|
| Phosphorylation | 23 | 2019 | 8436 | 0.580 |
Why?
|
| Biological Products | 2 | 2023 | 860 | 0.580 |
Why?
|
| Cell Cycle Proteins | 11 | 2019 | 3462 | 0.580 |
Why?
|
| Gene Duplication | 1 | 2018 | 329 | 0.570 |
Why?
|
| Lipoma | 8 | 2001 | 334 | 0.570 |
Why?
|
| Protein Kinase C | 6 | 2012 | 1227 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 7 | 9 | 2004 | 322 | 0.560 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2016 | 120 | 0.560 |
Why?
|
| PTEN Phosphohydrolase | 5 | 2021 | 1142 | 0.550 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2017 | 315 | 0.530 |
Why?
|
| Chromosomes, Human, Pair 6 | 5 | 2003 | 380 | 0.530 |
Why?
|
| Pyrroles | 10 | 2020 | 1146 | 0.530 |
Why?
|
| Stomach Neoplasms | 4 | 2014 | 1333 | 0.510 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2016 | 789 | 0.510 |
Why?
|
| Myofibroblasts | 1 | 2016 | 222 | 0.500 |
Why?
|
| Indoles | 10 | 2016 | 1839 | 0.500 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1861 | 0.500 |
Why?
|
| Neoplasm Invasiveness | 7 | 2017 | 3616 | 0.500 |
Why?
|
| Point Mutation | 3 | 2015 | 1623 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 15 | 6 | 2004 | 373 | 0.490 |
Why?
|
| Apoptosis | 27 | 2021 | 9727 | 0.470 |
Why?
|
| Gene Amplification | 9 | 2013 | 1063 | 0.470 |
Why?
|
| Neoplasm Proteins | 20 | 2016 | 3703 | 0.470 |
Why?
|
| Rhabdomyosarcoma | 6 | 2022 | 382 | 0.470 |
Why?
|
| Xenograft Model Antitumor Assays | 17 | 2021 | 3557 | 0.470 |
Why?
|
| Prostaglandin D2 | 1 | 2014 | 122 | 0.470 |
Why?
|
| Pyridines | 7 | 2019 | 2825 | 0.460 |
Why?
|
| Cytogenetics | 12 | 2016 | 203 | 0.450 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2022 | 2938 | 0.450 |
Why?
|
| Cell Survival | 13 | 2019 | 5882 | 0.450 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 130 | 0.450 |
Why?
|
| Phenylurea Compounds | 5 | 2019 | 528 | 0.440 |
Why?
|
| Hamartoma | 5 | 1997 | 238 | 0.440 |
Why?
|
| Molecular Sequence Data | 37 | 2014 | 18111 | 0.440 |
Why?
|
| Isoenzymes | 4 | 2012 | 1726 | 0.440 |
Why?
|
| Kidney Neoplasms | 17 | 2016 | 4262 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 13 | 2020 | 2942 | 0.430 |
Why?
|
| Mediator Complex | 1 | 2012 | 109 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 2009 | 323 | 0.420 |
Why?
|
| Smooth Muscle Tumor | 1 | 2012 | 67 | 0.420 |
Why?
|
| Gene Expression Profiling | 17 | 2019 | 9438 | 0.420 |
Why?
|
| Carrier Proteins | 5 | 2016 | 5021 | 0.420 |
Why?
|
| DNA, Neoplasm | 13 | 2010 | 1758 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 18 | 7 | 2010 | 245 | 0.410 |
Why?
|
| Tumor Cells, Cultured | 31 | 2021 | 6314 | 0.410 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2006 | 1519 | 0.400 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 169 | 0.400 |
Why?
|
| Receptor, IGF Type 1 | 5 | 2016 | 390 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 9 | 6 | 2020 | 535 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 19 | 5 | 2007 | 367 | 0.400 |
Why?
|
| Cell Cycle | 10 | 2019 | 2967 | 0.390 |
Why?
|
| Female | 162 | 2021 | 380194 | 0.390 |
Why?
|
| Exons | 11 | 2020 | 2437 | 0.380 |
Why?
|
| Protein Kinases | 4 | 2012 | 1640 | 0.380 |
Why?
|
| Receptors, Fibroblast Growth Factor | 3 | 2004 | 185 | 0.380 |
Why?
|
| Nuclear Proteins | 12 | 2023 | 5853 | 0.380 |
Why?
|
| Oncogenes | 9 | 2013 | 1265 | 0.380 |
Why?
|
| Chondrosarcoma | 4 | 2016 | 309 | 0.380 |
Why?
|
| Wilms Tumor | 6 | 2000 | 373 | 0.380 |
Why?
|
| Endopeptidases | 2 | 2004 | 772 | 0.380 |
Why?
|
| Fibromatosis, Aggressive | 2 | 2006 | 118 | 0.370 |
Why?
|
| Disease-Free Survival | 15 | 2018 | 6895 | 0.370 |
Why?
|
| Tropomyosin | 2 | 2020 | 102 | 0.370 |
Why?
|
| Carcinoma | 6 | 2014 | 2375 | 0.370 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 23 | 2016 | 4751 | 0.370 |
Why?
|
| Receptors, Growth Factor | 2 | 2011 | 334 | 0.360 |
Why?
|
| In Situ Hybridization | 8 | 2003 | 1950 | 0.360 |
Why?
|
| Repressor Proteins | 2 | 2018 | 3023 | 0.360 |
Why?
|
| Nerve Sheath Neoplasms | 4 | 2010 | 190 | 0.360 |
Why?
|
| DNA Mutational Analysis | 15 | 2018 | 4186 | 0.350 |
Why?
|
| Dyspepsia | 1 | 2010 | 115 | 0.350 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 3 | 2022 | 102 | 0.350 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2006 | 625 | 0.350 |
Why?
|
| Cadherins | 2 | 2004 | 907 | 0.350 |
Why?
|
| Enzyme Activation | 10 | 2014 | 3701 | 0.350 |
Why?
|
| Male | 147 | 2020 | 350118 | 0.350 |
Why?
|
| Cytogenetic Analysis | 5 | 2016 | 295 | 0.350 |
Why?
|
| ras Proteins | 2 | 2014 | 1060 | 0.340 |
Why?
|
| Base Sequence | 29 | 2014 | 12797 | 0.330 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2016 | 871 | 0.330 |
Why?
|
| Chondroblastoma | 2 | 2018 | 50 | 0.320 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 11 | 2014 | 3920 | 0.320 |
Why?
|
| Imidazoles | 6 | 2022 | 1206 | 0.320 |
Why?
|
| Loss of Heterozygosity | 2 | 2013 | 684 | 0.320 |
Why?
|
| Lung Neoplasms | 15 | 2021 | 13102 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 2004 | 197 | 0.310 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2009 | 265 | 0.310 |
Why?
|
| Cytological Techniques | 3 | 2007 | 219 | 0.310 |
Why?
|
| Receptor, erbB-2 | 5 | 2004 | 2416 | 0.300 |
Why?
|
| X Chromosome | 5 | 2002 | 814 | 0.300 |
Why?
|
| Prognosis | 31 | 2020 | 29063 | 0.300 |
Why?
|
| Chromosome Disorders | 7 | 2011 | 514 | 0.290 |
Why?
|
| Pyridazines | 2 | 2022 | 202 | 0.290 |
Why?
|
| Protein Kinase C-delta | 1 | 2007 | 123 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2021 | 2849 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2011 | 578 | 0.290 |
Why?
|
| RNA, Small Interfering | 9 | 2018 | 3505 | 0.290 |
Why?
|
| Artificial Gene Fusion | 4 | 2004 | 57 | 0.280 |
Why?
|
| Sulfonamides | 6 | 2021 | 1938 | 0.280 |
Why?
|
| Enzyme Inhibitors | 4 | 2009 | 3798 | 0.280 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2077 | 0.280 |
Why?
|
| Sarcoma, Clear Cell | 5 | 2012 | 76 | 0.270 |
Why?
|
| TOR Serine-Threonine Kinases | 7 | 2019 | 2109 | 0.270 |
Why?
|
| Chromosome Banding | 10 | 2016 | 278 | 0.270 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2022 | 538 | 0.270 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 526 | 0.270 |
Why?
|
| Succinate Dehydrogenase | 3 | 2017 | 146 | 0.260 |
Why?
|
| Doxorubicin | 4 | 2023 | 2234 | 0.260 |
Why?
|
| Mice, Nude | 10 | 2020 | 3689 | 0.260 |
Why?
|
| Gene Deletion | 8 | 2015 | 2751 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2019 | 9239 | 0.260 |
Why?
|
| Blotting, Western | 14 | 2016 | 5179 | 0.260 |
Why?
|
| Adult | 88 | 2020 | 214055 | 0.260 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 6 | 2015 | 188 | 0.260 |
Why?
|
| Middle Aged | 81 | 2020 | 213383 | 0.250 |
Why?
|
| Polymerase Chain Reaction | 12 | 2020 | 6171 | 0.250 |
Why?
|
| Mice | 43 | 2023 | 81183 | 0.250 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2008 | 324 | 0.250 |
Why?
|
| Skin Neoplasms | 11 | 2015 | 5686 | 0.240 |
Why?
|
| CHO Cells | 4 | 2019 | 1406 | 0.240 |
Why?
|
| Quinazolines | 3 | 2020 | 1356 | 0.240 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 4 | 2018 | 250 | 0.240 |
Why?
|
| Gene Expression | 10 | 2016 | 7799 | 0.240 |
Why?
|
| Animals | 58 | 2023 | 168757 | 0.240 |
Why?
|
| DNA Repair | 2 | 2023 | 2046 | 0.230 |
Why?
|
| RNA, Neoplasm | 8 | 2010 | 769 | 0.230 |
Why?
|
| Sarcoma, Synovial | 5 | 2002 | 167 | 0.230 |
Why?
|
| Neoplasms | 14 | 2022 | 21683 | 0.230 |
Why?
|
| Carcinoma, Renal Cell | 10 | 2016 | 3143 | 0.230 |
Why?
|
| Genes, myc | 4 | 2003 | 399 | 0.230 |
Why?
|
| Disease Progression | 14 | 2020 | 13284 | 0.220 |
Why?
|
| Child | 48 | 2020 | 77709 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2022 | 191 | 0.220 |
Why?
|
| Thiazolidinediones | 3 | 2002 | 476 | 0.220 |
Why?
|
| Fibrosarcoma | 3 | 2004 | 348 | 0.220 |
Why?
|
| Histones | 6 | 2018 | 2599 | 0.220 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2001 | 122 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2004 | 354 | 0.220 |
Why?
|
| Neoplasm Metastasis | 9 | 2020 | 4851 | 0.220 |
Why?
|
| Neurofibrosarcoma | 1 | 2022 | 24 | 0.210 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2023 | 117 | 0.210 |
Why?
|
| DNA, Complementary | 7 | 2004 | 2050 | 0.210 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 2015 | 234 | 0.210 |
Why?
|
| Gonadotropins | 1 | 2003 | 241 | 0.210 |
Why?
|
| Sickle Cell Trait | 2 | 2014 | 81 | 0.210 |
Why?
|
| Cell Movement | 7 | 2019 | 5217 | 0.210 |
Why?
|
| Cell Nucleus | 8 | 2019 | 2969 | 0.210 |
Why?
|
| Aged | 64 | 2020 | 163280 | 0.210 |
Why?
|
| Synovitis, Pigmented Villonodular | 2 | 1992 | 34 | 0.200 |
Why?
|
| Poly(A)-Binding Protein I | 1 | 2021 | 14 | 0.200 |
Why?
|
| Pyrazoles | 3 | 2021 | 1972 | 0.200 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 2 | 2021 | 177 | 0.200 |
Why?
|
| Gene Dosage | 5 | 2010 | 1252 | 0.200 |
Why?
|
| Zinc Fingers | 3 | 2004 | 585 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2014 | 286 | 0.200 |
Why?
|
| Granulosa Cell Tumor | 2 | 1992 | 71 | 0.200 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2002 | 224 | 0.200 |
Why?
|
| DNA | 7 | 2023 | 7301 | 0.190 |
Why?
|
| Melanoma | 7 | 2018 | 5510 | 0.190 |
Why?
|
| RNA Interference | 7 | 2016 | 2889 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2012 | 287 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 9 | 2019 | 4803 | 0.190 |
Why?
|
| Clinical Trials, Phase II as Topic | 2 | 2019 | 629 | 0.190 |
Why?
|
| Adolescent | 42 | 2018 | 85781 | 0.190 |
Why?
|
| Sulfides | 1 | 2021 | 165 | 0.190 |
Why?
|
| Genes, p16 | 1 | 2021 | 157 | 0.190 |
Why?
|
| Isochromosomes | 2 | 2000 | 16 | 0.190 |
Why?
|
| Amino Acid Sequence | 18 | 2021 | 13815 | 0.190 |
Why?
|
| High Mobility Group Proteins | 3 | 2006 | 187 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2006 | 1076 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2016 | 1434 | 0.180 |
Why?
|
| Breast Neoplasms, Male | 3 | 2003 | 210 | 0.180 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2020 | 37 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2022 | 322 | 0.180 |
Why?
|
| Receptor, Insulin | 3 | 2017 | 846 | 0.180 |
Why?
|
| Transfection | 9 | 2017 | 5892 | 0.180 |
Why?
|
| Gene Silencing | 4 | 2017 | 1538 | 0.180 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2000 | 84 | 0.180 |
Why?
|
| Interstitial Cells of Cajal | 3 | 2014 | 25 | 0.170 |
Why?
|
| Hydroxamic Acids | 2 | 2015 | 494 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2017 | 299 | 0.170 |
Why?
|
| Uveal Neoplasms | 2 | 2012 | 310 | 0.170 |
Why?
|
| Mesoderm | 7 | 2001 | 686 | 0.170 |
Why?
|
| Casein Kinase II | 1 | 2019 | 128 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 3597 | 0.170 |
Why?
|
| Stem Cell Factor | 2 | 2013 | 219 | 0.170 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 1504 | 0.170 |
Why?
|
| Breast Neoplasms | 13 | 2007 | 20822 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 1676 | 0.170 |
Why?
|
| Paired Box Transcription Factors | 2 | 2015 | 215 | 0.170 |
Why?
|
| Nitrophenols | 2 | 2016 | 172 | 0.170 |
Why?
|
| Nephroma, Mesoblastic | 1 | 1998 | 25 | 0.170 |
Why?
|
| Mitotic Index | 3 | 2012 | 172 | 0.170 |
Why?
|
| Antiprotozoal Agents | 1 | 2019 | 86 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2000 | 326 | 0.170 |
Why?
|
| Neurofibromin 1 | 3 | 2017 | 196 | 0.170 |
Why?
|
| Child, Preschool | 30 | 2020 | 41006 | 0.160 |
Why?
|
| Infant | 29 | 2020 | 35136 | 0.160 |
Why?
|
| I-kappa B Proteins | 1 | 2019 | 225 | 0.160 |
Why?
|
| Pathology | 1 | 2002 | 272 | 0.160 |
Why?
|
| Cell Differentiation | 9 | 2018 | 11483 | 0.160 |
Why?
|
| Proline | 1 | 2000 | 458 | 0.160 |
Why?
|
| Thyroid Neoplasms | 4 | 2010 | 2282 | 0.160 |
Why?
|
| Gene Fusion | 3 | 2020 | 371 | 0.160 |
Why?
|
| Inflammation | 2 | 2016 | 10638 | 0.160 |
Why?
|
| Alberta | 1 | 2018 | 64 | 0.160 |
Why?
|
| Behavior, Animal | 1 | 2006 | 1881 | 0.160 |
Why?
|
| Cricetulus | 2 | 2019 | 816 | 0.160 |
Why?
|
| Benzoquinones | 2 | 2011 | 201 | 0.160 |
Why?
|
| Chromosome Inversion | 1 | 1998 | 127 | 0.160 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 275 | 0.160 |
Why?
|
| Testicular Neoplasms | 3 | 2007 | 804 | 0.160 |
Why?
|
| Muscle Neoplasms | 1 | 2019 | 139 | 0.150 |
Why?
|
| Trans-Activators | 4 | 2004 | 2924 | 0.150 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1998 | 200 | 0.150 |
Why?
|
| RNA-Binding Protein EWS | 3 | 2006 | 216 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2016 | 730 | 0.150 |
Why?
|
| Pituitary Neoplasms | 2 | 2003 | 1345 | 0.150 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2018 | 116 | 0.150 |
Why?
|
| Vinculin | 2 | 2014 | 62 | 0.150 |
Why?
|
| Models, Biological | 3 | 2007 | 9583 | 0.150 |
Why?
|
| Lactams, Macrocyclic | 2 | 2011 | 320 | 0.150 |
Why?
|
| Survival Rate | 9 | 2017 | 12788 | 0.150 |
Why?
|
| Muscle Proteins | 2 | 2021 | 1159 | 0.150 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 2016 | 15 | 0.150 |
Why?
|
| Receptors, Somatomedin | 1 | 2016 | 57 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 2 | 2019 | 498 | 0.140 |
Why?
|
| Prenatal Diagnosis | 2 | 2016 | 1236 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2021 | 1012 | 0.140 |
Why?
|
| Immunoenzyme Techniques | 4 | 2004 | 1799 | 0.140 |
Why?
|
| Myeloproliferative Disorders | 2 | 2004 | 606 | 0.140 |
Why?
|
| Neurilemmoma | 4 | 2014 | 547 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 3772 | 0.140 |
Why?
|
| Carcinoma in Situ | 2 | 1999 | 806 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 11 | 4 | 2003 | 417 | 0.140 |
Why?
|
| Ring Chromosomes | 1 | 1995 | 22 | 0.140 |
Why?
|
| Thiazoles | 4 | 2010 | 1483 | 0.140 |
Why?
|
| Salvage Therapy | 2 | 2019 | 1275 | 0.130 |
Why?
|
| Threonine | 2 | 2014 | 279 | 0.130 |
Why?
|
| Gene Order | 1 | 2016 | 176 | 0.130 |
Why?
|
| Co-Repressor Proteins | 3 | 2012 | 194 | 0.130 |
Why?
|
| Tumor Burden | 7 | 2020 | 1915 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2021 | 1692 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2018 | 449 | 0.130 |
Why?
|
| Neurofibromin 2 | 1 | 2016 | 267 | 0.130 |
Why?
|
| Fibromatosis, Abdominal | 1 | 1995 | 24 | 0.130 |
Why?
|
| Golgi Apparatus | 1 | 2017 | 410 | 0.130 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2016 | 215 | 0.130 |
Why?
|
| Karyopherins | 1 | 2016 | 137 | 0.130 |
Why?
|
| Adenoma | 4 | 2000 | 2174 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1998 | 403 | 0.130 |
Why?
|
| Chloride Channels | 2 | 2013 | 227 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2015 | 15519 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2014 | 459 | 0.130 |
Why?
|
| Biphenyl Compounds | 2 | 2016 | 913 | 0.130 |
Why?
|
| Laryngeal Neoplasms | 3 | 2003 | 512 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2012 | 100 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 6 | 2014 | 5867 | 0.120 |
Why?
|
| DNA Primers | 6 | 2014 | 2892 | 0.120 |
Why?
|
| Gene Library | 2 | 2013 | 1074 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 1998 | 658 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1999 | 1101 | 0.120 |
Why?
|
| Down-Regulation | 5 | 2016 | 3002 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 5 | 2020 | 2727 | 0.120 |
Why?
|
| Metaphase | 4 | 2001 | 151 | 0.120 |
Why?
|
| Hydrazines | 1 | 2016 | 226 | 0.120 |
Why?
|
| Sequence Deletion | 3 | 2010 | 1526 | 0.120 |
Why?
|
| Blotting, Southern | 5 | 2003 | 803 | 0.120 |
Why?
|
| Deoxyglucose | 1 | 2015 | 337 | 0.120 |
Why?
|
| Pulmonary Blastoma | 2 | 2006 | 33 | 0.120 |
Why?
|
| Isoleucine | 1 | 2014 | 112 | 0.120 |
Why?
|
| Ascitic Fluid | 1 | 1994 | 192 | 0.120 |
Why?
|
| Genotype | 10 | 2020 | 12951 | 0.120 |
Why?
|
| Endometrial Hyperplasia | 1 | 1995 | 97 | 0.120 |
Why?
|
| Mutation, Missense | 4 | 2010 | 2564 | 0.120 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1549 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 2015 | 251 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 2 | 2007 | 320 | 0.120 |
Why?
|
| Hemangiopericytoma | 1 | 1994 | 77 | 0.120 |
Why?
|
| DNA Damage | 1 | 2023 | 2432 | 0.120 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 2187 | 0.120 |
Why?
|
| MyoD Protein | 1 | 2014 | 151 | 0.120 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 211 | 0.120 |
Why?
|
| Membrane Proteins | 3 | 2020 | 7880 | 0.120 |
Why?
|
| Genetic Markers | 8 | 2012 | 2634 | 0.110 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2013 | 37 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2019 | 11524 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2014 | 197 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2013 | 27 | 0.110 |
Why?
|
| Retinoblastoma Protein | 3 | 2015 | 704 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 399 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 6 | 2015 | 6386 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1999 | 2214 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2013 | 1941 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2010 | 12720 | 0.110 |
Why?
|
| Carcinoid Tumor | 1 | 2014 | 235 | 0.110 |
Why?
|
| Triterpenes | 1 | 2013 | 80 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2004 | 4034 | 0.110 |
Why?
|
| Staurosporine | 2 | 2004 | 251 | 0.110 |
Why?
|
| Carcinoma, Papillary | 3 | 2007 | 783 | 0.110 |
Why?
|
| Osteopontin | 1 | 2014 | 296 | 0.110 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1992 | 44 | 0.110 |
Why?
|
| Chromosomes, Artificial, Yeast | 5 | 2001 | 118 | 0.110 |
Why?
|
| Biopsy | 5 | 2018 | 6756 | 0.110 |
Why?
|
| Isoindoles | 1 | 2012 | 41 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2018 | 17446 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 1994 | 180 | 0.110 |
Why?
|
| Iodide Peroxidase | 1 | 2014 | 293 | 0.110 |
Why?
|
| Muscle Development | 1 | 2014 | 271 | 0.100 |
Why?
|
| Liposarcoma, Myxoid | 2 | 2007 | 67 | 0.100 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2012 | 42 | 0.100 |
Why?
|
| Mucous Membrane | 2 | 2013 | 673 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 452 | 0.100 |
Why?
|
| Chromosome Mapping | 9 | 2004 | 4740 | 0.100 |
Why?
|
| Liver Neoplasms | 3 | 1999 | 4253 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2018 | 3523 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 3 | 1997 | 45 | 0.100 |
Why?
|
| Adenocarcinoma | 4 | 1997 | 6364 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1992 | 374 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2010 | 1117 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 390 | 0.100 |
Why?
|
| Sunlight | 1 | 2013 | 325 | 0.100 |
Why?
|
| Pleural Effusion | 1 | 1994 | 338 | 0.100 |
Why?
|
| Mutant Proteins | 2 | 2010 | 500 | 0.100 |
Why?
|
| Cricetinae | 3 | 2004 | 2472 | 0.100 |
Why?
|
| Europe | 1 | 2018 | 3339 | 0.100 |
Why?
|
| Polyps | 1 | 1992 | 189 | 0.100 |
Why?
|
| Protein Binding | 6 | 2021 | 9386 | 0.100 |
Why?
|
| Brain Neoplasms | 6 | 2015 | 8863 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 2 | 2007 | 873 | 0.100 |
Why?
|
| Ploidies | 5 | 1996 | 281 | 0.090 |
Why?
|
| Glycine | 1 | 2014 | 671 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1991 | 133 | 0.090 |
Why?
|
| Pilomatrixoma | 1 | 2010 | 23 | 0.090 |
Why?
|
| Facial Neoplasms | 2 | 2004 | 121 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 4 | 2002 | 569 | 0.090 |
Why?
|
| Carbonic Anhydrase II | 1 | 2010 | 23 | 0.090 |
Why?
|
| Cell Respiration | 1 | 2010 | 201 | 0.090 |
Why?
|
| Triazoles | 1 | 2016 | 911 | 0.090 |
Why?
|
| Arginine | 1 | 2014 | 944 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2023 | 670 | 0.090 |
Why?
|
| Lentivirus | 1 | 2013 | 501 | 0.090 |
Why?
|
| Ovarian Neoplasms | 4 | 2007 | 4838 | 0.090 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2010 | 84 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2015 | 986 | 0.090 |
Why?
|
| Niacinamide | 1 | 2012 | 417 | 0.090 |
Why?
|
| Aged, 80 and over | 20 | 2018 | 57776 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 6538 | 0.090 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2003 | 286 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5221 | 0.090 |
Why?
|
| Phenanthrolines | 1 | 2009 | 55 | 0.090 |
Why?
|
| Hair Diseases | 1 | 2010 | 74 | 0.090 |
Why?
|
| Zebrafish | 2 | 2019 | 2994 | 0.090 |
Why?
|
| Intestinal Neoplasms | 2 | 2010 | 319 | 0.090 |
Why?
|
| Young Adult | 10 | 2018 | 56430 | 0.090 |
Why?
|
| Esophageal pH Monitoring | 1 | 2010 | 191 | 0.090 |
Why?
|
| Receptor, trkA | 2 | 2020 | 164 | 0.090 |
Why?
|
| Tyrosine | 2 | 2007 | 1461 | 0.090 |
Why?
|
| Time Factors | 6 | 2018 | 40075 | 0.090 |
Why?
|
| Hashimoto Disease | 1 | 2010 | 97 | 0.080 |
Why?
|
| Treatment Outcome | 9 | 2019 | 63114 | 0.080 |
Why?
|
| Phenotype | 4 | 2018 | 16365 | 0.080 |
Why?
|
| Ependymoma | 1 | 1992 | 334 | 0.080 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 675 | 0.080 |
Why?
|
| Actins | 3 | 2007 | 2121 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2014 | 658 | 0.080 |
Why?
|
| Adamantinoma | 1 | 2008 | 9 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1526 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 1 | 1994 | 665 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 905 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 281 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 434 | 0.080 |
Why?
|
| Up-Regulation | 4 | 2019 | 4217 | 0.080 |
Why?
|
| Sulfones | 1 | 2011 | 437 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 1655 | 0.080 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 216 | 0.080 |
Why?
|
| Transcription, Genetic | 7 | 2013 | 7722 | 0.080 |
Why?
|
| Struma Ovarii | 1 | 2007 | 10 | 0.080 |
Why?
|
| Collagen Type I | 2 | 2015 | 592 | 0.080 |
Why?
|
| Cell Division | 8 | 2004 | 4568 | 0.080 |
Why?
|
| Lung Diseases | 2 | 1995 | 1886 | 0.080 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2008 | 54 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2010 | 434 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 1989 | 254 | 0.070 |
Why?
|
| Desmin | 1 | 2007 | 130 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2010 | 551 | 0.070 |
Why?
|
| Neoplasms, Fibrous Tissue | 1 | 2007 | 25 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2014 | 2839 | 0.070 |
Why?
|
| Genes | 2 | 2001 | 1893 | 0.070 |
Why?
|
| Dioxoles | 1 | 2007 | 104 | 0.070 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2007 | 91 | 0.070 |
Why?
|
| Game Theory | 1 | 2006 | 25 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2013 | 3748 | 0.070 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2006 | 26 | 0.070 |
Why?
|
| Mice, SCID | 4 | 2019 | 2716 | 0.070 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1986 | 64 | 0.070 |
Why?
|
| Spectral Karyotyping | 1 | 2006 | 12 | 0.070 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2006 | 42 | 0.070 |
Why?
|
| Cloning, Molecular | 6 | 2003 | 4320 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 1990 | 934 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2011 | 1460 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1986 | 193 | 0.070 |
Why?
|
| Protein Transport | 1 | 2012 | 1988 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2004 | 6544 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 1995 | 65 | 0.070 |
Why?
|
| Genes, sis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2005 | 111 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 2015 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2006 | 1682 | 0.070 |
Why?
|
| Leukemia, B-Cell | 1 | 2005 | 86 | 0.060 |
Why?
|
| Boronic Acids | 1 | 2009 | 965 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4204 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 738 | 0.060 |
Why?
|
| Keratins | 3 | 1997 | 515 | 0.060 |
Why?
|
| Disease Models, Animal | 6 | 2016 | 18029 | 0.060 |
Why?
|
| Genes, Immunoglobulin | 1 | 2005 | 291 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 493 | 0.060 |
Why?
|
| Altruism | 1 | 2006 | 204 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 1681 | 0.060 |
Why?
|
| Genetic Techniques | 2 | 1999 | 435 | 0.060 |
Why?
|
| Sirolimus | 2 | 2014 | 1564 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 868 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2012 | 625 | 0.060 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2006 | 252 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 12354 | 0.060 |
Why?
|
| Paraffin Embedding | 2 | 2003 | 299 | 0.060 |
Why?
|
| RNA, Messenger | 7 | 2012 | 13033 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2016 | 10943 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2010 | 2043 | 0.060 |
Why?
|
| Genome, Human | 3 | 2014 | 4420 | 0.060 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2004 | 72 | 0.060 |
Why?
|
| Heart Neoplasms | 2 | 2000 | 374 | 0.060 |
Why?
|
| Chromosome Breakage | 2 | 2002 | 173 | 0.060 |
Why?
|
| Adipocytes | 2 | 2009 | 1184 | 0.060 |
Why?
|
| Pyrazines | 1 | 2009 | 1230 | 0.060 |
Why?
|
| Cell Line | 8 | 2013 | 15997 | 0.060 |
Why?
|
| Medical Oncology | 1 | 1995 | 2265 | 0.060 |
Why?
|
| Antibodies | 1 | 2012 | 2460 | 0.060 |
Why?
|
| Neoplasm Transplantation | 4 | 2019 | 2085 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 782 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2014 | 4286 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12245 | 0.060 |
Why?
|
| Intestine, Small | 1 | 2010 | 1241 | 0.060 |
Why?
|
| Blotting, Northern | 4 | 2001 | 1581 | 0.060 |
Why?
|
| Phosphotransferases | 1 | 2004 | 308 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2012 | 2499 | 0.060 |
Why?
|
| Clone Cells | 3 | 2007 | 1692 | 0.060 |
Why?
|
| Haploidy | 1 | 2023 | 136 | 0.060 |
Why?
|
| Neuroectodermal Tumors, Primitive | 2 | 1994 | 140 | 0.060 |
Why?
|
| Positron-Emission Tomography | 3 | 2009 | 6234 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 5 | 2018 | 9274 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 627 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2022 | 17 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2003 | 1723 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 3 | 2003 | 118 | 0.060 |
Why?
|
| Cavernous Sinus | 1 | 2004 | 125 | 0.050 |
Why?
|
| Fluorescence | 3 | 2012 | 751 | 0.050 |
Why?
|
| Seminoma | 1 | 2004 | 137 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 657 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 255 | 0.050 |
Why?
|
| Skull Neoplasms | 1 | 2003 | 173 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2000 | 1085 | 0.050 |
Why?
|
| Parotid Neoplasms | 1 | 2003 | 155 | 0.050 |
Why?
|
| Vascular Neoplasms | 1 | 2004 | 175 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2003 | 321 | 0.050 |
Why?
|
| Radiation Tolerance | 2 | 1996 | 486 | 0.050 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2002 | 104 | 0.050 |
Why?
|
| Biopsy, Needle | 5 | 2003 | 1641 | 0.050 |
Why?
|
| Flow Cytometry | 5 | 2015 | 5974 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1285 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2005 | 835 | 0.050 |
Why?
|
| Indazoles | 2 | 2014 | 289 | 0.050 |
Why?
|
| bcl-X Protein | 2 | 2016 | 411 | 0.050 |
Why?
|
| Urethane | 1 | 2021 | 40 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2006 | 541 | 0.050 |
Why?
|
| Syndrome | 3 | 2010 | 3251 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2010 | 2504 | 0.050 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2001 | 41 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1878 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2006 | 914 | 0.050 |
Why?
|
| Chromosome Painting | 1 | 2001 | 27 | 0.050 |
Why?
|
| Dura Mater | 1 | 2003 | 291 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2012 | 140 | 0.050 |
Why?
|
| Pericytes | 1 | 2004 | 292 | 0.050 |
Why?
|
| Retroelements | 1 | 2022 | 164 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2016 | 1792 | 0.050 |
Why?
|
| Survival Analysis | 6 | 2021 | 10252 | 0.050 |
Why?
|
| Collagen | 2 | 2000 | 2689 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2004 | 11124 | 0.050 |
Why?
|
| Lipomatosis, Multiple Symmetrical | 1 | 2000 | 9 | 0.050 |
Why?
|
| Histocytochemistry | 2 | 1998 | 719 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2017 | 3128 | 0.050 |
Why?
|
| beta Catenin | 1 | 2006 | 1059 | 0.050 |
Why?
|
| Phosphoproteins | 3 | 2007 | 2440 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2004 | 1730 | 0.050 |
Why?
|
| Burkitt Lymphoma | 2 | 2003 | 327 | 0.050 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2000 | 113 | 0.050 |
Why?
|
| Binding Sites | 3 | 2010 | 6114 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2000 | 128 | 0.050 |
Why?
|
| Phenazines | 1 | 2019 | 58 | 0.040 |
Why?
|
| Mitosis | 2 | 2014 | 1208 | 0.040 |
Why?
|
| Cyclin E | 1 | 2000 | 172 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2004 | 596 | 0.040 |
Why?
|
| Aneuploidy | 4 | 2003 | 530 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2004 | 587 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39050 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2007 | 1903 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 457 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 2 | 1993 | 180 | 0.040 |
Why?
|
| Transcriptional Activation | 3 | 2001 | 1783 | 0.040 |
Why?
|
| Kinetics | 1 | 2007 | 6473 | 0.040 |
Why?
|
| Testis | 1 | 2003 | 803 | 0.040 |
Why?
|
| Naphthyridines | 1 | 2019 | 118 | 0.040 |
Why?
|
| Multigene Family | 3 | 2010 | 1102 | 0.040 |
Why?
|
| Monosomy | 2 | 2004 | 54 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2014 | 20129 | 0.040 |
Why?
|
| Neuroblastoma | 2 | 1998 | 1226 | 0.040 |
Why?
|
| Protein Methyltransferases | 1 | 2018 | 55 | 0.040 |
Why?
|
| Response Elements | 1 | 2000 | 312 | 0.040 |
Why?
|
| Receptor, trkC | 1 | 1998 | 68 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4931 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 1094 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1998 | 70 | 0.040 |
Why?
|
| Plasma Cell Granuloma, Pulmonary | 1 | 1998 | 13 | 0.040 |
Why?
|
| Triazines | 1 | 2020 | 315 | 0.040 |
Why?
|
| Giant Cell Tumors | 1 | 1998 | 99 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2001 | 675 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3444 | 0.040 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 1999 | 180 | 0.040 |
Why?
|
| Colorimetry | 1 | 1998 | 147 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1986 | 2617 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2021 | 6489 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2007 | 3690 | 0.040 |
Why?
|
| Lymphoma, T-Cell | 1 | 2000 | 299 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1454 | 0.040 |
Why?
|
| Infant, Newborn | 6 | 2004 | 25625 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2012 | 126 | 0.040 |
Why?
|
| Peritoneal Diseases | 1 | 1998 | 75 | 0.040 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 2016 | 340 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1998 | 318 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 14722 | 0.040 |
Why?
|
| DNA Probes | 2 | 1995 | 560 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 634 | 0.040 |
Why?
|
| Diagnosis, Differential | 5 | 2014 | 12959 | 0.040 |
Why?
|
| Kidney | 1 | 1993 | 7186 | 0.040 |
Why?
|
| COS Cells | 1 | 2019 | 1161 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2010 | 220 | 0.040 |
Why?
|
| Genes, ras | 2 | 2007 | 690 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2004 | 1375 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2009 | 180 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 671 | 0.040 |
Why?
|
| Image Cytometry | 1 | 1997 | 54 | 0.040 |
Why?
|
| HMGA1a Protein | 1 | 1997 | 64 | 0.040 |
Why?
|
| Fibroma | 1 | 1998 | 212 | 0.040 |
Why?
|
| Phagocytosis | 2 | 2013 | 1539 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 479 | 0.040 |
Why?
|
| Phthalazines | 1 | 2019 | 363 | 0.040 |
Why?
|
| Androgens | 1 | 2004 | 1281 | 0.040 |
Why?
|
| Retinoids | 1 | 1997 | 101 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 798 | 0.040 |
Why?
|
| RNA | 2 | 2004 | 2749 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2012 | 4445 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1998 | 689 | 0.030 |
Why?
|
| Heterozygote | 4 | 2013 | 2804 | 0.030 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 1996 | 39 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2013 | 10180 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2003 | 931 | 0.030 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 1998 | 169 | 0.030 |
Why?
|
| Lung | 3 | 1997 | 9856 | 0.030 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1996 | 58 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2008 | 1832 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 232 | 0.030 |
Why?
|
| Culture Techniques | 2 | 1997 | 554 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 1998 | 381 | 0.030 |
Why?
|
| HLA-DQ Antigens | 2 | 1993 | 210 | 0.030 |
Why?
|
| Nucleic Acid Precursors | 1 | 2015 | 15 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1996 | 136 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 733 | 0.030 |
Why?
|
| Introns | 3 | 2004 | 991 | 0.030 |
Why?
|
| Glioblastoma | 2 | 2009 | 3481 | 0.030 |
Why?
|
| Mucin-1 | 2 | 1997 | 543 | 0.030 |
Why?
|
| Diploidy | 2 | 1998 | 138 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 5524 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 1998 | 740 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2010 | 1899 | 0.030 |
Why?
|
| Freezing | 1 | 1995 | 303 | 0.030 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1995 | 114 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 15076 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 19905 | 0.030 |
Why?
|
| Cisplatin | 2 | 2016 | 1662 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 1241 | 0.030 |
Why?
|
| Chromosomes, Human, 13-15 | 2 | 2004 | 52 | 0.030 |
Why?
|
| Centromere | 1 | 1995 | 220 | 0.030 |
Why?
|
| Remission Induction | 3 | 2005 | 2386 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 3129 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2002 | 1584 | 0.030 |
Why?
|
| Asbestos, Amosite | 1 | 1994 | 1 | 0.030 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 1994 | 41 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2001 | 3588 | 0.030 |
Why?
|
| Butadienes | 1 | 2014 | 110 | 0.030 |
Why?
|
| Genes, Wilms Tumor | 1 | 1994 | 94 | 0.030 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 1994 | 49 | 0.030 |
Why?
|
| United States | 2 | 2018 | 69872 | 0.030 |
Why?
|
| Chromones | 1 | 2014 | 154 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12261 | 0.030 |
Why?
|
| raf Kinases | 1 | 2014 | 122 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 4149 | 0.030 |
Why?
|
| Mosaicism | 2 | 1998 | 441 | 0.030 |
Why?
|
| Niflumic Acid | 1 | 2013 | 10 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 2126 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2009 | 2505 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2013 | 17 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2010 | 3752 | 0.030 |
Why?
|
| DNA Replication | 1 | 2000 | 1399 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1997 | 560 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 135 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2012 | 11031 | 0.030 |
Why?
|
| Maleimides | 1 | 2013 | 112 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1995 | 362 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2010 | 53288 | 0.030 |
Why?
|
| SOXD Transcription Factors | 1 | 2013 | 47 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2017 | 841 | 0.030 |
Why?
|
| Aminophenols | 1 | 2013 | 78 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 563 | 0.030 |
Why?
|
| Schwann Cells | 1 | 1994 | 195 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2007 | 563 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2013 | 109 | 0.030 |
Why?
|
| Proteins | 3 | 2000 | 6103 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 15 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14557 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 4933 | 0.030 |
Why?
|
| Chromosome Walking | 1 | 2012 | 27 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 1994 | 212 | 0.030 |
Why?
|
| Sex Factors | 2 | 2015 | 10397 | 0.030 |
Why?
|
| Methods | 1 | 1992 | 1129 | 0.030 |
Why?
|
| Cysts | 1 | 1998 | 678 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2002 | 2038 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2016 | 600 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2007 | 1572 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1994 | 457 | 0.030 |
Why?
|
| Fibroblasts | 4 | 1997 | 4161 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 98 | 0.030 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1992 | 101 | 0.030 |
Why?
|
| Microscopy, Electron | 3 | 2001 | 2645 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 112 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2014 | 5456 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 1126 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 594 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1991 | 128 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 893 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 322 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 430 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 1038 | 0.020 |
Why?
|
| Genome | 1 | 2000 | 1808 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 1992 | 457 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2015 | 542 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 365 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2000 | 3279 | 0.020 |
Why?
|
| Electron Transport Complex II | 1 | 2010 | 48 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 323 | 0.020 |
Why?
|
| Reference Values | 2 | 1995 | 4982 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 571 | 0.020 |
Why?
|
| Alleles | 3 | 2001 | 6933 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2000 | 1378 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 544 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 537 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1157 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 1106 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1708 | 0.020 |
Why?
|
| Ovary | 1 | 1995 | 981 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 2010 | 182 | 0.020 |
Why?
|
| Vimentin | 1 | 1991 | 261 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1827 | 0.020 |
Why?
|
| Germ-Line Mutation | 2 | 2010 | 1788 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1994 | 726 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 1172 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2014 | 1266 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 509 | 0.020 |
Why?
|
| Imides | 1 | 2009 | 15 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 1993 | 936 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 758 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2015 | 850 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2017 | 4026 | 0.020 |
Why?
|
| Genes, jun | 1 | 2009 | 71 | 0.020 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1990 | 109 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2013 | 19229 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2009 | 135 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 4462 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21827 | 0.020 |
Why?
|
| Mucins | 1 | 1992 | 564 | 0.020 |
Why?
|
| Retrospective Studies | 7 | 2020 | 77449 | 0.020 |
Why?
|
| Philadelphia Chromosome | 1 | 1989 | 112 | 0.020 |
Why?
|
| Hemangioma | 1 | 1994 | 738 | 0.020 |
Why?
|
| Neurofibroma | 1 | 2010 | 106 | 0.020 |
Why?
|
| Paraganglioma | 1 | 2010 | 143 | 0.020 |
Why?
|
| Quinolines | 1 | 2014 | 732 | 0.020 |
Why?
|
| Risk Factors | 3 | 2012 | 72290 | 0.020 |
Why?
|
| Nitriles | 1 | 2014 | 956 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 648 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2703 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 677 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 557 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2009 | 194 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1999 | 3760 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 2004 | 829 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2014 | 1050 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3340 | 0.020 |
Why?
|
| DNA, Antisense | 1 | 2007 | 46 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2007 | 31 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 611 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 3386 | 0.020 |
Why?
|
| Glioma | 2 | 2009 | 3401 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2000 | 4665 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2009 | 644 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2007 | 158 | 0.020 |
Why?
|
| Isomerism | 1 | 2007 | 201 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 959 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2009 | 626 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2013 | 956 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2255 | 0.020 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2006 | 25 | 0.020 |
Why?
|
| Piperidines | 1 | 2015 | 1602 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 1986 | 170 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1998 | 3474 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1085 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1994 | 1061 | 0.020 |
Why?
|
| Clinical Enzyme Tests | 1 | 1986 | 115 | 0.020 |
Why?
|
| Mast Cells | 1 | 1994 | 1544 | 0.020 |
Why?
|
| SOXE Transcription Factors | 1 | 2006 | 57 | 0.020 |
Why?
|
| Genomics | 2 | 2014 | 5720 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2006 | 335 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 1997 | 4328 | 0.020 |
Why?
|
| Muscles | 1 | 1991 | 1614 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2007 | 271 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2010 | 689 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1791 | 0.020 |
Why?
|
| Albumins | 1 | 2008 | 569 | 0.020 |
Why?
|
| Fatal Outcome | 2 | 2001 | 1850 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 728 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 2004 | 192 | 0.020 |
Why?
|
| Chromosomes, Human, 19-20 | 1 | 2003 | 12 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2003 | 2699 | 0.020 |
Why?
|
| Diaphragm | 2 | 1998 | 349 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2000 | 2256 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1992 | 2765 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 2004 | 65 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 1990 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 1917 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2008 | 729 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2008 | 1588 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2010 | 1341 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 40561 | 0.010 |
Why?
|
| Skin | 2 | 1993 | 4364 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 712 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2003 | 96 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1994 | 1796 | 0.010 |
Why?
|
| Germinoma | 1 | 2004 | 133 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2007 | 35421 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1986 | 707 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 103 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 3846 | 0.010 |
Why?
|
| Ligands | 2 | 2002 | 3282 | 0.010 |
Why?
|
| Melanocytes | 1 | 2006 | 515 | 0.010 |
Why?
|
| Chromatin | 2 | 2007 | 2934 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2715 | 0.010 |
Why?
|
| Laminin | 1 | 2004 | 419 | 0.010 |
Why?
|
| Models, Genetic | 2 | 2004 | 3494 | 0.010 |
Why?
|
| Radiography | 2 | 2007 | 7023 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2008 | 1166 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2002 | 155 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2002 | 202 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 2003 | 444 | 0.010 |
Why?
|
| Drug Discovery | 1 | 2010 | 1058 | 0.010 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2001 | 57 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 514 | 0.010 |
Why?
|
| Epiglottis | 1 | 2001 | 79 | 0.010 |
Why?
|
| Bone Marrow | 2 | 2006 | 2948 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2001 | 318 | 0.010 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2001 | 53 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3647 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 2016 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2005 | 973 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 2866 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.010 |
Why?
|
| Activin Receptors | 1 | 2000 | 43 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 599 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9734 | 0.010 |
Why?
|
| Contig Mapping | 1 | 1999 | 54 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2003 | 294 | 0.010 |
Why?
|
| Age Factors | 1 | 1997 | 18370 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3870 | 0.010 |
Why?
|
| Leg | 1 | 2005 | 1116 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 1785 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2003 | 880 | 0.010 |
Why?
|
| Color | 1 | 2001 | 307 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 8949 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2001 | 399 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1997 | 5256 | 0.010 |
Why?
|
| Inhibins | 1 | 2000 | 211 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 423 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 1039 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2003 | 491 | 0.010 |
Why?
|
| Follistatin | 1 | 2000 | 141 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2000 | 422 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2001 | 802 | 0.010 |
Why?
|
| Physical Examination | 1 | 2005 | 1237 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 1706 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 440 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1364 | 0.010 |
Why?
|
| Activins | 1 | 2000 | 208 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2001 | 659 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 1940 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2000 | 464 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 2728 | 0.010 |
Why?
|
| Dibenzoxazepines | 1 | 1978 | 8 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 2513 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1993 | 3336 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9146 | 0.010 |
Why?
|
| Macrophages | 1 | 2013 | 5655 | 0.010 |
Why?
|
| Myoglobin | 1 | 1998 | 160 | 0.010 |
Why?
|
| Gene Expression Regulation | 3 | 2003 | 12072 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 733 | 0.010 |
Why?
|
| Skin Absorption | 1 | 1978 | 94 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21746 | 0.010 |
Why?
|
| Growth Substances | 1 | 2000 | 784 | 0.010 |
Why?
|
| Proteomics | 1 | 2010 | 3638 | 0.010 |
Why?
|
| Pedigree | 1 | 2005 | 4644 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 1997 | 93 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 840 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1997 | 352 | 0.010 |
Why?
|
| Chromosomes | 1 | 2000 | 596 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 2902 | 0.010 |
Why?
|
| Solvents | 1 | 1978 | 302 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1997 | 230 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 3922 | 0.010 |
Why?
|
| Caspases | 1 | 1999 | 928 | 0.010 |
Why?
|
| Myosins | 1 | 1998 | 409 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8340 | 0.010 |
Why?
|
| Permeability | 1 | 1978 | 738 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6196 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2242 | 0.010 |
Why?
|
| Neutrophils | 1 | 2008 | 3719 | 0.010 |
Why?
|
| Liver | 1 | 1991 | 7474 | 0.010 |
Why?
|
| HMGA2 Protein | 1 | 1995 | 123 | 0.010 |
Why?
|
| Intermediate Filaments | 1 | 1995 | 175 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2003 | 3479 | 0.010 |
Why?
|
| Breast | 1 | 2003 | 1969 | 0.010 |
Why?
|
| Asbestos, Amphibole | 1 | 1994 | 7 | 0.010 |
Why?
|
| Polycythemia | 1 | 1994 | 126 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1997 | 927 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1995 | 565 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 427 | 0.010 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1994 | 151 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2000 | 1381 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1992 | 441 | 0.010 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1992 | 79 | 0.010 |
Why?
|
| Pleura | 1 | 1994 | 235 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1994 | 537 | 0.010 |
Why?
|
| Artifacts | 1 | 2001 | 1904 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2000 | 2263 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1992 | 101 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1997 | 1381 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1992 | 321 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1992 | 768 | 0.010 |
Why?
|
| Rabbits | 1 | 1978 | 4894 | 0.010 |
Why?
|
| Temperature | 1 | 1978 | 2206 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1997 | 2421 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1993 | 645 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6622 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 2915 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 2362 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8642 | 0.010 |
Why?
|
| Calcinosis | 1 | 1999 | 1499 | 0.010 |
Why?
|
| Epithelium | 1 | 1995 | 1679 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1997 | 1821 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 1224 | 0.010 |
Why?
|
| Rats | 2 | 1994 | 24260 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 29144 | 0.010 |
Why?
|
| Specimen Handling | 1 | 1994 | 694 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 13881 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1993 | 1475 | 0.010 |
Why?
|
| Risk | 1 | 2000 | 9687 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1997 | 1889 | 0.000 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 1708 | 0.000 |
Why?
|
| Placenta | 1 | 1997 | 1698 | 0.000 |
Why?
|
| Radiation Dosage | 1 | 1996 | 1928 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 2007 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1994 | 2382 | 0.000 |
Why?
|
| Linear Models | 1 | 1996 | 5952 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 3617 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1992 | 1782 | 0.000 |
Why?
|
| Research Design | 1 | 2001 | 5987 | 0.000 |
Why?
|
| Incidence | 1 | 2003 | 20947 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8301 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 23338 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1993 | 2958 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 26385 | 0.000 |
Why?
|